無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ニードルフリー・デリバリ技術の世界市場の展望 (2018年〜2028年):ジェット注射器技術、競合技術 (新型ニードル技術、吸入器技術、経皮パッチ技術)

Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology

発行 Visiongain Ltd 商品コード 233147
出版日 ページ情報 英文 183 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=150.33円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
ニードルフリー・デリバリ技術の世界市場の展望 (2018年〜2028年):ジェット注射器技術、競合技術 (新型ニードル技術、吸入器技術、経皮パッチ技術) Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology
出版日: 2018年08月21日 ページ情報: 英文 183 Pages
概要

世界のニードルフリー薬剤送達 (ドラッグデリバリ) の市場規模は、2017年には17億米ドル、2028年には55億米ドルと、11.5%のCAGR (複合年間成長率) で拡大する見込みです。2017年現在、市場の45.1%をジェット注射器が占めています。

当レポートでは、無針 (ニードルフリー) デリバリーの世界市場について調査分析しており、ニードルフリー・デリバリ技術の必要性や利点・欠点、現在利用可能な/開発中の主要製品 (ジェット注射器、競合技術) の概要、市場規模の動向見通し、各国市場の詳細動向、主な市場促進・抑制要因、主要企業のプロファイル・主力製品・業績見通し、今後の市場動向の方向性などをまとめています。

第1章 分析概要

第2章 ニードルフリー・デリバリ技術の概略

  • 無針 (ニードルフリー) デリバリ技術とは何か?
  • ニードルフリー・デリバリ技術の市場
  • ニードルフリー・デリバリ技術が有用となる臨床現場
    • 疼痛管理
    • ワクチンデリバリ:免疫反応の改善
    • 糖尿病向けインスリン・デリバリ
    • 小児用注射
    • 他の利用法
  • ニードルフリー・デリバリ技術市場に関する規制 (米国・欧州)
  • バイオ医薬品

第3章 ニードルフリー・デリバリ技術:世界市場

  • 市場概要
  • 市場の内訳
  • 市場の将来予測 (今後12年間分)
  • 部門別市場シェアの変動見通し
  • 今後の市場動向
  • 市場促進・抑制要因

第4章 ジェット注射器技術市場

  • ジェット注射器技術:概要
  • ジェット注射器技術:市場予測 (今後12年間分)
  • ジェット注射器の主要製品 (全15製品)
  • ジェット注射器の開発パイプライン (全7製品)

第5章 競合するニードルフリー・デリバリ技術の市場

  • 競合技術の概要
  • 競合技術の市場:将来予測 (今後11年間分)
  • 競合技術の市場:部門別市場シェアの変動見通し
  • 新型のニードル技術:概要
  • 新型ニードル技術:市場予測 (今後11年間分)
    • 主要製品 (全5製品)
    • パイプライン製品 (全11製品)
  • 吸入器技術:概要
  • 吸入器技術:市場予測 (今後12年間分)
    • 喘息向け吸入器
      • 防止薬吸入器
      • 緩和薬吸入器
    • インスリン用吸入器
    • ワクチン用吸入器
  • 経皮パッチ技術:概要
  • 経皮パッチ技術:市場予測 (今後12年間分)
    • 主要な経皮パッチ製品 (全4製品)
    • 経皮パッチ技術の開発パイプライン (全4製品)
  • 開発中のその他の競合技術 (全4製品)

第6章 主要国市場 (今後11年間分)

  • 世界のニードルフリー・デリバリ技術市場:地域別の将来予測 (今後11年間分)
    • 地域別市場シェアの変動見通し
  • 米国市場
  • 欧州主要5ヶ国市場 (EU5:ドイツ・フランス・英国・イタリア・スペイン)
  • 日本市場
  • 中国市場
  • インド市場
  • 他の国々 (RoW) の市場

第7章 ニードルフリー・デリバリ技術の代表的企業

  • ニードルフリー・デリバリ技術の主要メーカー
  • Antares Pharma
  • Zogenix
  • 3M
  • Becton Dickinson and Company (BD)
  • PharmaJet
  • BioJect Medical Technologies

第8章 ニードルフリー・デリバリ技術市場の定質分析

  • ニードルフリー・デリバリ技術のSWOT分析
  • 強み
    • バイオ医薬品市場の大幅な成長
    • 経皮デリバリ技術の進歩
    • 専門的訓練が不要で、事故も生じないこと
    • コールドチェーン問題の回避
  • 弱み
    • 新たなデリバリ装置に不慣れな医療従事者
    • 規制・検査の強化
    • 非効率的な製造工程
  • 機会
    • 新興国市場における巨大な成長機会
    • 世界各地での集団予防接種プログラム
    • 在宅治療への移行
    • 薬剤のライフサイクルの延長
  • 脅威
    • 従来型の注射針・シリンジ:大量生産による製造コストの低さ
    • 事故防止技術つき注射針・シリンジ
    • 臨床データの不足
    • 医療機器向け物品税

第9章 結論

  • 現在の主力部門
    • 注目すべき企業
    • 主要国市場
  • 世界市場の将来予測 (今後11年間分)
  • ニードルフリー・デリバリ技術市場の将来像
    • バイオシミラー:ニードルフリー・デリバリ技術市場の強力な促進要因
    • 強力なパイプライン製品:ニードルフリー・デリバリ技術の促進要因

付録

  • 用語集
図表

List of Tables

  • Table 2.1: Classification of Jet Injectors by Method of Propulsion
  • Table 2.2: Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3: Pen Needle Technology by Needle Length
  • Table 2.4: Rationale for Needle-Free Vaccine Delivery
  • Table 2.5: Examples of Needle-Free Vaccine Delivery Systems, 2016
  • Table 2.6: Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2016
  • Table 2.7: FDA Guidance on Regulation of Needle-Free Injectors, 2015
  • Table 2.8: Top 5 Biologics by Sales ($bn), 2015
  • Table 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2015
  • Table 3.2: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 3.3: Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2015, 2020 and 2026
  • Table 4.1: The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.1: The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.2: Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2015
  • Table 5.3: Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.4: Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.5: Leading Products in the Asthma Preventer Inhaler Market, 2016
  • Table 5.6: Leading Products in the Asthma Reliever Inhaler Market, 2016
  • Table 5.7: Vaccine Inhalers Currently Under Development, 2016
  • Table 5.8: Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 5.9: Transdermal Patch Products, 2016
  • Table 6.1: Global Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%) by Region, 2015-2026
  • Table 6.2: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Table 6.3: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Table 6.4: US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.5: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.6: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015, 2020 and 2026
  • Table 6.7: German Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.8: French Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.9: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.10: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.11: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.12: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 6.13: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
  • Table 6.14: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
  • Table 7.1: Antares Pharma: Overview, 2016
  • Table 7.2: Antares Pharma: 2016 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3: Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.4: Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2014 and 2015
  • Table 7.5: Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.6: Antares Pharma: Products in Development 2016 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7: Zogenix: Overview, 2016
  • Table 7.8: Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 7.9: Zogenix: Revenue ($m) by Type, 2010-2015
  • Table 7.10: 3M: Overview, 2016
  • Table 7.11: 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.12: BD: Overview, 2016
  • Table 7.13: BD: Drug Delivery Products by Segment, 2016
  • Table 7.14: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Table 7.15: BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 7.16: PharmaJet: Overview, 2016
  • Table 7.17: BioJect Medical Technologies: Overview, 2016
  • Table 7.18: Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19: Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 8.1: SWOT Analysis of the Needle-Free Delivery Technology Market, 2016-2026
  • Table 8.2: Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2015

List of Figures

  • Figure 1.1: Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
  • Figure 2.1: Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1: The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 3.2: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2015
  • Figure 3.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 3.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 3.5: Needle-Free Delivery Technology: Drivers and Restraints 2016-2026
  • Figure 4.1: The Jet Injectors Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.1: The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.2: Market Shares (%) of Competing Needle-Free Technology Market Segments, 2015
  • Figure 5.3: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
  • Figure 5.4: Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
  • Figure 5.5: Novel Needle Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.6: Inhaler Technology Market: Revenue ($m), AGR (%), 2015-2026
  • Figure 5.7: Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.1: Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
  • Figure 6.2: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2020
  • Figure 6.3: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2020-2026
  • Figure 6.4: Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2026
  • Figure 6.5: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
  • Figure 6.6: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2020
  • Figure 6.7: Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2026
  • Figure 6.8: US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.9: EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%), 2015-2026
  • Figure 6.10: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015
  • Figure 6.11: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2020
  • Figure 6.12: EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2026
  • Figure 6.13: German Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.14: French Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.15: UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.16: Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
  • Figure 6.17: Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.18: Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.19: Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.20: Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 7.1: Antares Revenue from Major Customers: Revenue Share (%), 2014
  • Figure 7.2: Antares Revenue from Major Customers: Revenue Share (%), 2015
  • Figure 7.3: Antares Revenue by Region: Revenue Share (%), 2014
  • Figure 7.4: Antares Revenue by Region: Revenue Share (%), 2015
  • Figure 7.5: Antares Pharma: Historical Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.6: Zogenix: Revenue ($m) and AGR (%), 2010-2015
  • Figure 7.7: Zogenix: Revenue ($m) by Type, 2014
  • Figure 7.8: Zogenix: Revenue ($m) by Type, 2015
  • Figure 7.9: 3M: Health Care Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.10: BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
  • Figure 7.11: BD Medical: Historical Revenue ($bn) and AGR (%), 2010-2015
  • Figure 7.12: Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13: Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1: The Transport Process for a Vaccine

Companies Listed

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organisations Mentioned in the Report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital
目次
Product Code: PHA0327

The global needle-free delivery technology market was valued at $1.7bn in 2017 and is estimated to reach $5.5bn by 2028, growing at a CAGR of 11.5% from 2018-2028. In 2017, the Jet Injectors submarket held 45.1% of the global needle-free delivery technology market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 183-page report you will receive 107 charts - all unavailable elsewhere.

The 183-page report provides clear detailed insight into the global needle-free delivery technology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Needle-Free Delivery Technology market forecasts from 2018-2028
  • Jet Injector submarket forecasts from 2018-2028
  • Competing Technology submarket forecast from 2018-2028, further segmented into:
    • Novel Needle Technology
    • Inhaler Technology
    • Patch Technology
  • This report also breaks down the revenue forecast for global needle-free delivery technology market by regional and national market:
    • The US
    • EU5: Germany, France, UK, Italy, Spain
    • Japan
    • China
    • India

image1

  • This report discusses the leading companies that are involved in the needle-free delivery technology market. It contains overviews of the companies' activities, strategies and recent financial results:
    • 3M
    • Antares Pharma
    • Becton Dickinson
    • BioJect Medical Technologies
    • PharmaJet
    • Zogenix
  • This report provides a SWOT Analysis of the global needle-free delivery technology market.

Visiongain's study is for everybody needing commercial analyses for the needle-free delivery technology market and leading companies. You will find data, trends and predictions. Please order our report now.

Table of Contents

1. Report Overview

  • 1.1 Global Needle-Free Delivery Technology Market Overview
  • 1.2 Global Needle-Free Delivery Technology Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report For?
  • 1.7 Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to Needle-Free Delivery Technology

  • 2.1 What is Needle-Free Delivery Technology?
    • 2.1.1 Needlestick Injury
      • 2.1.1.1 Blood-Borne Pathogens and Needlestick Injury
      • 2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem
  • 2.2 The Needle-Free Delivery Technology Market
    • 2.2.1 Jet Injectors
      • 2.2.1.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
      • 2.2.1.2 Strengths and Weaknesses of Jet Injectors
    • 2.2.2 Competing Needle-Free Technologies
      • 2.2.2.1 Novel Needle Technology
      • 2.2.2.2 Pen Needles
      • 2.2.2.3 Microneedles
      • 2.2.2.4 Hollow Microneedles
      • 2.2.2.5 Solid Coated Microneedles
      • 2.2.2.6 Solid Biodegradable Microneedles
      • 2.2.2.7 Solid Uncoated Microneedles
      • 2.2.2.8 Using the Right Microneedles
      • 2.2.2.9 Inhaler Technology
      • 2.2.2.10 Transdermal Patch Technology
  • 2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
    • 2.3.1 Pain Management
      • 2.3.1.1 Using Needle-Free Injection Devices to Administer Lidocaine
    • 2.3.2 Vaccine Delivery: Improving Immune Response
      • 2.3.2.1 Needle-Free Vaccine Delivery
      • 2.3.2.2 Mass Immunisation
    • 2.3.3 Insulin Delivery for Diabetics
    • 2.3.4 Paediatric Injections
    • 2.3.5 Other Uses for Needle-Free Injection Technology
  • 2.4 Regulation of the Needle-Free Delivery Technology Market
    • 2.4.1 The US Regulation System
      • 2.4.1.1 Combination Products
      • 2.4.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-Approved Needle-Free Devices
    • 2.4.2 The European Regulation System
      • 2.4.2.1 Post Marketing Surveillance in the EU
  • 2.5 Biopharmaceuticals
    • 2.5.1 An Introduction to the Biological Drugs Market
    • 2.5.2 Biologics: A Rising Drugs Market

3. Needle-Free Delivery Technology: Global Market 2018-2028

  • 3.1 The Needle-Free Delivery Technology Market: Overview
  • 3.2 Needle-Free Delivery Technology Market Segmentation, 2017
  • 3.3 The Needle-Free Delivery Technology Market Forecast, 2017-2028
  • 3.4 How Will Segmental Market Shares Change to 2028?
  • 3.5 Needle-Free Delivery Technology: Market Trends, 2018-2028
  • 3.6 Needle-Free Delivery Technology: Drivers and Restraints 2018-2028

4. Jet Injectors Technology Market, 2018-2028

  • 4.1 The Jet Injectors Market Overview
  • 4.2 Jet Injectors: Market Forecast 2017-2028
  • 4.3 Jet Injector Devices on the Market
    • 4.3.1 Biojector 2000 (Bioject Medical Technologies)
    • 4.3.2 ZetaJet (Bioject Medical Technologies)
    • 4.3.3 Vision (Antares Pharma)
    • 4.3.4 Vibex (Antares Pharma)
    • 4.3.5 Sumavel DosePro (Endo International)
    • 4.3.6 Stratis (PharmaJet)
    • 4.3.7 LectraJet (D'Antonio Consultants International)
    • 4.3.8 AdvantaJet and GentleJet (Activa Brand Products)
    • 4.3.9 Vitajet (Bioject Medical Technologies)
    • 4.3.10 Med-Jet (Medical International Technologies)
    • 4.3.11 J-Tip (National Medical Products)
    • 4.3.12 Injex30 (Injex Pharma)
    • 4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak)
    • 4.3.14 E-Jet 100 (Eurojet Medical)
    • 4.3.15 Penjet (Penjet Corporation)
  • 4.4 Jet Injectors Development Pipeline
    • 4.4.1 Glide SDI (Glide Pharmaceutical Technologies)
    • 4.4.2 Zeneo (Crossject)
    • 4.4.3 Relday (Zogenix)
    • 4.4.4 Magnetic Injection (Massachusetts Institute of Technology)
    • 4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies)
    • 4.4.6 Iject and Iject R (Bioject Medical Technologies)
    • 4.4.7 Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2018-2028

  • 5.1 The Competing Needle-Free Technology Overview
  • 5.2 The Competing Technology: Market Forecast 2017-2028
  • 5.3 How Will Segmental Market Shares Change to 2028?
  • 5.4 Novel Needle Technology Overview
  • 5.5 Novel Needle Technology: Market Forecast, 2018-2028
    • 5.5.1 Leading Novel Needle Technologies
      • 5.5.1.1 Soluvia Microinjection System (BD)
      • 5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD)
      • 5.5.1.3 AutoShield Duo Pen Needle (BD)
      • 5.5.1.4 Microstructured Transdermal Systems (3M)
      • 5.5.1.5 ZP Patch Technology (Zosano)
    • 5.5.2 Novel Needle Technology Development Pipeline
      • 5.5.2.1 Microneedle Patch (Georgia Institute of Technology)
      • 5.5.2.2 Micronjet (NanoPass)
      • 5.5.2.3 DebioJect (Debiotech)
      • 5.5.2.4 AdminPen (nanoBioSciences)
      • 5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp)
      • 5.5.2.6 DrugMat and VaxMat (TheraJect)
      • 5.5.2.7 MicroCor (Corium International)
      • 5.5.2.8 Nanopatch (Vaxxas)
      • 5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
      • 5.5.2.10 Memspatch and Micro-Patch (Nemaura)
      • 5.5.2.11 Microneedle Patch for Lidocaine Delivery (National University of Singapore)
  • 5.6 Inhaler Technology Overview
  • 5.7 Inhaler Technology: Market Forecast, 2017-2028
    • 5.7.1 Inhaler Products in the Asthma Market
      • 5.7.1.1 Preventer Inhalers
      • 5.7.1.2 Reliever Inhalers
    • 5.7.2 Inhaler Products in the Insulin Market
    • 5.7.3 Inhaler Products in the Vaccine Market: FluMist Quadrivalent (MedImmune)
      • 5.7.3.1 Pipeline
  • 5.8 Transdermal Patch Technology Overview
  • 5.9 Transdermal Patch Technology: Market Forecast, 2017-2028
    • 5.9.1 Selected Transdermal Patch Products
      • 5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals)
      • 5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline)
      • 5.9.1.3 Exelon Patch (Rivastigmine, Novartis)
      • 5.9.1.4 Zecuity (Sumatriptan, Teva)
    • 5.9.2 Transdermal Patch Technology Development Pipeline
      • 5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma)
      • 5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
      • 5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
      • 5.9.2.4 Prelude SkinPrep System (Echo Therapeutics)
  • 5.10 Other Competing Needle-free delivery Technology in development
    • 5.10.1 Microbubbles Injection (Shibaura Institute of Technology)
    • 5.10.2 Laser Injection (Seoul National University)
    • 5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
    • 5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2017-2028

  • 6.1 Global Needle-Free Delivery Technology Market: Regional Forecast 2018-2028
    • 6.1.1 How Will Regional Market Shares Change to 2026?
  • 6.2 The US Needle-Free Delivery Technology Market 2018-2028
    • 6.2.1 US Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.2.2 FDA Guideline for Combination Products
    • 6.2.3 Needle-Free Delivery and the US Flu Vaccination Market
    • 6.2.4 Measles Outbreak in the US
  • 6.3 The EU5 Needle-Free Delivery Technology Market 2017-2028
    • 6.3.1 EU5 Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.3.2 Germany Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.3 France Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.4 The UK Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.5 Italy Needle-Free Delivery Technology Market Forecast, 2018-2028
    • 6.3.6 Spain Needle-Free Delivery Technology Market Forecast, 2018-2028
  • 6.4 Japan Needle-Free Delivery Technology Market 2018-2028
    • 6.4.1 Japan Needle-Free Delivery Technology Market Forecast 2018-2028
  • 6.5 China Needle-Free Delivery Technology Market 2018-2028
    • 6.5.1 China Needle-Free Delivery Technology Market Forecast 2018-2028
  • 6.6 India Needle-Free Delivery Technology Market 2018-2028
    • 6.6.1 India Needle-Free Delivery Technology Market Forecast 2018-2028
    • 6.6.2 Needles and Syringes being Re-used in Indian Hospitals
  • 6.7 The Rest of the World (RoW) Needle-Free Delivery Technology Market 2018-2028
    • 6.7.1 RoW Needle-Free Delivery Technology Market Forecast 2018-2028

7. Leading Companies in the Needle-Free Delivery Technology Market

  • 7.1 Leading Needle-Free Delivery Technology Manufacturers in 2017
  • 7.2 Antares Pharma: Leading the Needle-Free Injector Market
    • 7.2.1 Antares Pharma: Needle-Free Technology Product Portfolio
    • 7.2.2 Antares Pharma: Future Outlook
    • 7.2.3 Antares Pharma: Products in Development
    • 7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
  • 7.3 Zogenix
    • 7.3.1 Zogenix: Product Portfolio
    • 7.3.2 Zogenix: Current Pipeline
    • 7.3.3 Zogenix: Financial Overview
  • 7.4 3M: 50 Years of Drug Delivery Technology Development
    • 7.4.1 3M: Drug Delivery Technology Portfolio
    • 7.4.1.1 Oral and Topical Drug Delivery
    • 7.4.1.2 MDI for Nasal and Inhalable Drugs
    • 7.4.1.3 Transdermal patch Technology
    • 7.4.1.4 Microneedle Technology
    • 7.4.2 3M: Market Outlook
  • 7.5 Becton Dickinson and Company (BD)
    • 7.5.1 BD: Drug Delivery Technology Portfolio
    • 7.5.1.1 Prefillable Syringe Systems
    • 7.5.1.2 Self-Injection Systems
    • 7.5.1.3 Pen Needles
    • 7.5.1.4 Safety & Shielding Systems
    • 7.5.2 BD: Future Outlook
    • 7.5.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
    • 7.5.4 BD Acquired Injection Safety Firms
    • 7.5.5 Recall of BD Needles in Hong Kong
  • 7.6 PharmaJet
    • 7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio
    • 7.6.2 First FDA Approved Jet Injector for Flu Shot in the US
    • 7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
    • 7.6.4 Preference for PharmaJet over Needle and Syringe
  • 7.7 BioJect Medical Technologies
    • 7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
    • 7.7.2 Bioject Medical Technologies: Financial Overview
    • 7.7.3 Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market 2017-2028

  • 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market
  • 8.2 Strengths
    • 8.2.1 Strong Growth in the Biologic Drug Market
    • 8.2.2 Increasing Development in Transdermal Delivery
    • 8.2.3 No Specialist Training Required and No Needlestick Injuries
    • 8.2.4 Eliminating the Cold Chain Problem
  • 8.3 Weaknesses
    • 8.3.1 Healthcare Practitioners are not familiar with Novel Delivery Systems
    • 8.3.2 Greater Regulatory Scrutiny
    • 8.3.3 Inefficient Manufacturing Processes
  • 8.4 Opportunities
    • 8.4.1 Emerging Economies Offer Significant Growth Opportunities
    • 8.4.2 Mass Immunisation Programmes around the World
    • 8.4.3 Increasing Global Diabetic Population
    • 8.4.4 Shift towards Home Administration Setting
    • 8.4.5 Extending Life Cycle of Drugs
  • 8.5 Threats
    • 8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
    • 8.5.2 Needle and Syringes with Anti Needlestick Injury Technology
    • 8.5.3 Limited Clinical Data
    • 8.5.4 Medical Device Excise Tax

9. Conclusions

  • 9.1 Current Leading Needle-Free Technology Segments
    • 9.1.1 Notable Needle-Free Technology Companies
    • 9.1.2 Leading Regional Markets
  • 9.2 Global Needle-Free Technology Market Forecast 2018-2028
  • 9.3 The Future of the Needle-Free Technology Market
    • 9.3.1 Biosimilars are a Major Driver of the Needle-free Delivery Market
    • 9.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

Appendices

  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 2.1 Classification of Jet Injectors by Method of Propulsion
  • Table 2.2 Strengths and Weaknesses of the Jet Injector Market
  • Table 2.3 Pen Needle Technology by Needle Length
  • Table 2.4 Rationale for Needle-Free Vaccine Delivery
  • Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2017
  • Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2017
  • Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2017
  • Table 2.8 Top 5 Biologics by Sales ($bn) in U.S, 2017
  • Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2017
  • Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 3.3 Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2017, 2022 and 2028
  • Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.2 Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2017
  • Table 5.3 Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.4 Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.5 Leading Products in the Asthma Preventer Inhaler Market, 2017
  • Table 5.6 Leading Products in the Asthma Reliever Inhaler Market, 2017
  • Table 5.7 Vaccine Inhalers Currently Under Development, 2017
  • Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 5.9 Transdermal Patch Products, 2017
  • Table 6.1 Global Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%) by Region, 2017-2028
  • Table 6.2 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2017-2028
  • Table 6.3 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Table 6.4 US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.5 EU5 Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.6 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2017, 2022 and 2028
  • Table 6.7 Germany Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.8 France Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.9 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2017-2028
  • Table 6.10 Italy Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.11 Spain Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.12 Japan Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.13 China Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2017-2028
  • Table 6.14 India Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 6.15 RoW Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 7.1 Antares Pharma: Overview, 2017
  • Table 7.2 Antares Pharma: 2017 Product Portfolio (Product, Drug, Partner, Indication and Territory
  • Table 7.3 Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2016 and 2017
  • Table 7.4 Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2016 and 2017
  • Table 7.5 Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2013-2017
  • Table 7.6 Antares Pharma: Products in Development 2017 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
  • Table 7.7 Zogenix: Overview, 2017
  • Table 7.8 Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2013-2017
  • Table 7.9 Zogenix: Revenue ($m) by Type, 2016 & 2017
  • Table 7.10 3M: Overview, 2017
  • Table 7.11 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2013-2017
  • Table 7.12 BD: Overview, 2017
  • Table 7.13 BD: Drug Delivery Products by Segment, 2017
  • Table 7.14 BD: Historical Revenue ($bn) by Geographic Region, 2013-2017
  • Table 7.15 BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2013-2017
  • Table 7.16 PharmaJet: Overview, 2017
  • Table 7.17 BioJect Medical Technologies: Overview, 2017
  • Table 7.18 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
  • Table 7.19 Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2014
  • Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2017-2028
  • Table 8.2 Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2017

List of Figures

  • Figure 1.1 Global Needle-Free Delivery Technology Market Segmentation Overview, 2017
  • Figure 2.1 Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
  • Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2017-2028
  • Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2017
  • Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2022
  • Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2028
  • Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints
  • Figure 4.1 The Jet Injectors Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2017
  • Figure 5.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2022
  • Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2028
  • Figure 5.5 Novel Needle Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2017-2028
  • Figure 5.7 Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2017-2028
  • Figure 6.1 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Figure 6.2 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2017-2022
  • Figure 6.3 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2022-2028
  • Figure 6.4 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2017-2028
  • Figure 6.5 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2017
  • Figure 6.6 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2022
  • Figure 6.7 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2028
  • Figure 6.8 US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.9 EU5 Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), 2017-2028
  • Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2017
  • Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2022
  • Figure 6.12 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2028
  • Figure 6.13 Germany Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.14 France Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.15 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.16 Italy Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.17 Spain Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.18 Japan Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.19 China Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.20 India Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 6.21 RoW Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2017-2028
  • Figure 7.1 Antares Revenue from Major Customers: Revenue Share (%), 2016
  • Figure 7.2 Antares Revenue from Major Customers: Revenue Share (%), 2017
  • Figure 7.3 Antares Revenue by Region: Revenue Share (%), 2016
  • Figure 7.4 Antares Revenue by Region: Revenue Share (%), 2017
  • Figure 7.5 Antares Pharma: Historical Revenue ($m) and AGR (%), 2013-2017
  • Figure 7.6 Zogenix: Revenue ($m) and AGR (%), 2013-2017
  • Figure 7.7 Zogenix: Revenue ($m) by Type, 2016
  • Figure 7.8 Zogenix: Revenue ($m) by Type, 2017
  • Figure 7.9 3M: Health Care Historical Revenue ($bn) and AGR (%), 2013-2017
  • Figure 7.10 BD: Historical Revenue ($bn) by Geographic Region, 2013-2017
  • Figure 7.11 BD Medical: Historical Revenue ($bn) and AGR (%), 2013-2015
  • Figure 7.12 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
  • Figure 7.13 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
  • Figure 8.1 The Transport Process for a Vaccine

COMPANIES LISTED

  • 3M
  • Actavis
  • Activa Brand Products
  • AcuShot
  • Adamis
  • Aktiv-Dry
  • Alkermes
  • Alza
  • Anesiva
  • Antares Pharma
  • Aradigm
  • Astellas Pharma
  • AstraZeneca
  • BD
  • BeadTek
  • Berlex Labs
  • Bespak
  • bioCSL
  • Bioject Medical Technologies
  • Biomedics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb and Somerset Pharmaceuticals
  • Cambridge Consultants
  • CareFusion Corporation
  • CEA-LETI
  • Corium International
  • CosMed
  • Crossject
  • CureVac
  • D'Antonio Consultants International
  • Debiotech
  • Durect
  • Echo Therapeutics
  • Elcam Medical
  • Eli Lilly & Co
  • Endo International
  • Ethical Holdings/Schering
  • Eurojet Medical
  • Ferndale
  • Georgia Institute of Technology
  • Giant Eagle
  • GlaxoSmithKline
  • Glide Pharmaceutical Technologies
  • Hangzhou Hema Medical Equipment
  • Haselmeir GmbH
  • Health-Mor Personal Care
  • Hirtenberger
  • Ichor
  • iHealthNet
  • Immunomic Therapeutics
  • ImmusanT
  • Injex Pharma
  • Inovio Pharmaceuticals
  • Invion
  • Janssen Pharmaceuticals
  • Key Pharmaceuticals
  • Kroger
  • LEO Pharma
  • LTS Lohmann Therapie-Systeme
  • MannKind
  • Mecaplast
  • Meda Pharmaceuticals
  • Medac Pharma
  • Medical International Technologies
  • Medi-Ject
  • MedImmune
  • Merck
  • Merck Serono
  • Micron Biomedical
  • Mylan
  • nanoBioSciences
  • NanoPass
  • Napp Pharmaceuticals
  • National Medical Products
  • Nektar Therapeutics
  • Nemaura
  • Nicobrand Limited
  • Novartis
  • Novo Nordisk
  • Novogyne Pharmaceuticals
  • NuPathe
  • Nycomed
  • Ortho-McNeil
  • Owen MumFord Inc
  • Par Pharmaceutical
  • Parke-Davis
  • Penjet Corporation
  • Permatec
  • Pernix
  • Pfizer
  • PharmaJet
  • PKA SoftTouch Corp
  • Procter & Gamble
  • ProStrakan
  • Purdue Pharma
  • Radius Health
  • Rhenovia Pharma
  • Rite Aid
  • Roche
  • Sandoz
  • Sanofi
  • Searle Pharmaceuticals
  • Shire
  • SHL Group AB
  • Shwarz-Pharma
  • Société Nationale des Poudres et Explosifs
  • STADA Arzneimittel AG
  • Stat Medical Devices
  • Takeda
  • Teva
  • Tev-Tropin
  • The Medical House
  • TheraJect
  • TheraTech
  • Transdermal Specialties
  • Trimeris
  • Trinity-Chiesi
  • UCB Pharma
  • University of California-San Francisco
  • Vaxxas
  • Vetter Pharma
  • Vyteris
  • Watson
  • West Pharmaceuticals
  • Westmount Pharmacy
  • Ypsomed AG
  • Zogenix
  • Zosano
  • Zydus Cadila

Organizations Mentioned in the report

  • Ankara University
  • Atlanta's Emory University
  • Bill & Melinda Gates Foundation
  • Gwangju Institute of Science and Technology
  • Indian Institute of Science, Bangalore
  • Massachusetts Institute of Technology
  • National University of Singapore
  • Oxford University
  • Seoul National University
  • Shibaura Institute of Technology
  • University of Texas
  • University of Wisconsin's Hospital
Back to Top